Bolden Therapeutics
Providence, RI
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.
boldentherapeutics.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $3,300,880
Headquarters Location
- Providence, RI
Public
- No
Acquired
- No
CEO
Johnny Page
Founders
- Johnny Page
Company Collections
These are collections Bolden Therapeutics is a part of. Click on the collection name to view similar companies.